Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 7.42850977 |
2 | response to muscle activity (GO:0014850) | 7.17919190 |
3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.04380805 |
4 | skeletal muscle fiber development (GO:0048741) | 6.71280619 |
5 | cardiac myofibril assembly (GO:0055003) | 6.67058998 |
6 | myofibril assembly (GO:0030239) | 6.33572297 |
7 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.33451390 |
8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.16569212 |
9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.12056427 |
10 | myotube cell development (GO:0014904) | 6.10958392 |
11 | cardiac muscle contraction (GO:0060048) | 5.87076766 |
12 | actin-myosin filament sliding (GO:0033275) | 5.81775963 |
13 | muscle filament sliding (GO:0030049) | 5.81775963 |
14 | plasma membrane repair (GO:0001778) | 5.80289075 |
15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.67414059 |
16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.63041738 |
17 | regulation of skeletal muscle contraction (GO:0014819) | 5.54798330 |
18 | regulation of actin filament-based movement (GO:1903115) | 5.40142151 |
19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.37939978 |
20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.36568666 |
21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.32094947 |
22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.25105485 |
23 | tricarboxylic acid cycle (GO:0006099) | 5.21582053 |
24 | glycogen biosynthetic process (GO:0005978) | 5.16813431 |
25 | glucan biosynthetic process (GO:0009250) | 5.16813431 |
26 | muscle fiber development (GO:0048747) | 5.07633660 |
27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.03891526 |
28 | cellular polysaccharide catabolic process (GO:0044247) | 5.03119250 |
29 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.00542833 |
30 | striated muscle contraction (GO:0006941) | 4.90798940 |
31 | skeletal muscle tissue development (GO:0007519) | 4.90220563 |
32 | cell communication involved in cardiac conduction (GO:0086065) | 4.89376527 |
33 | cell communication by electrical coupling (GO:0010644) | 4.82579895 |
34 | regulation of relaxation of muscle (GO:1901077) | 4.79479741 |
35 | actomyosin structure organization (GO:0031032) | 4.77941055 |
36 | actin-mediated cell contraction (GO:0070252) | 4.77442285 |
37 | carnitine shuttle (GO:0006853) | 4.68600736 |
38 | cardiac muscle cell development (GO:0055013) | 4.65683719 |
39 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.64858937 |
40 | skeletal muscle tissue regeneration (GO:0043403) | 4.57208267 |
41 | adult heart development (GO:0007512) | 4.56759885 |
42 | regulation of membrane repolarization (GO:0060306) | 4.54198105 |
43 | polysaccharide catabolic process (GO:0000272) | 4.53026030 |
44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.47466934 |
45 | muscle cell cellular homeostasis (GO:0046716) | 4.44371584 |
46 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.42691422 |
47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.40417615 |
48 | regulation of striated muscle contraction (GO:0006942) | 4.38738224 |
49 | cardiac cell development (GO:0055006) | 4.34416510 |
50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.34312935 |
51 | cardiac muscle hypertrophy (GO:0003300) | 4.22536390 |
52 | fructose metabolic process (GO:0006000) | 4.20175437 |
53 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.15604883 |
54 | glycogen metabolic process (GO:0005977) | 4.15202816 |
55 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.07320736 |
56 | glucan metabolic process (GO:0044042) | 4.06966760 |
57 | cellular glucan metabolic process (GO:0006073) | 4.06966760 |
58 | striated muscle hypertrophy (GO:0014897) | 4.06064964 |
59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.03960478 |
60 | gluconeogenesis (GO:0006094) | 4.02230098 |
61 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.99448577 |
62 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.98882591 |
63 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.96883642 |
64 | fatty acid transmembrane transport (GO:1902001) | 3.95105116 |
65 | muscle organ morphogenesis (GO:0048644) | 3.93862473 |
66 | regulation of sarcomere organization (GO:0060297) | 3.93708420 |
67 | striated muscle cell development (GO:0055002) | 3.93429652 |
68 | regulation of cofactor metabolic process (GO:0051193) | 3.92845952 |
69 | regulation of coenzyme metabolic process (GO:0051196) | 3.92845952 |
70 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.91780767 |
71 | regulation of the force of heart contraction (GO:0002026) | 3.90449050 |
72 | cardiac muscle cell action potential (GO:0086001) | 3.89966486 |
73 | muscle structure development (GO:0061061) | 3.89857950 |
74 | muscle organ development (GO:0007517) | 3.88216469 |
75 | response to activity (GO:0014823) | 3.85740052 |
76 | muscle cell fate commitment (GO:0042693) | 3.84277172 |
77 | positive regulation of myotube differentiation (GO:0010831) | 3.83491043 |
78 | striated muscle atrophy (GO:0014891) | 3.79898454 |
79 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.79380010 |
80 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.79380010 |
81 | muscle adaptation (GO:0043500) | 3.77223196 |
82 | regulation of cardiac muscle contraction (GO:0055117) | 3.74997762 |
83 | positive regulation of cation channel activity (GO:2001259) | 3.74375223 |
84 | muscle tissue morphogenesis (GO:0060415) | 3.74127931 |
85 | skeletal muscle contraction (GO:0003009) | 3.72537022 |
86 | creatine metabolic process (GO:0006600) | 3.68471742 |
87 | IMP metabolic process (GO:0046040) | 3.65710928 |
88 | actin filament-based movement (GO:0030048) | 3.65552304 |
89 | cardiac conduction (GO:0061337) | 3.64373502 |
90 | myoblast fusion (GO:0007520) | 3.63418928 |
91 | relaxation of cardiac muscle (GO:0055119) | 3.61400117 |
92 | hexose biosynthetic process (GO:0019319) | 3.59148762 |
93 | NADH metabolic process (GO:0006734) | 3.58791430 |
94 | heart trabecula formation (GO:0060347) | 3.56620477 |
95 | potassium ion import (GO:0010107) | 3.54997488 |
96 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.54569092 |
97 | regulation of heart rate (GO:0002027) | 3.54002090 |
98 | muscle hypertrophy (GO:0014896) | 3.53503469 |
99 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.52682323 |
100 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.51482620 |
101 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.51482620 |
102 | detection of calcium ion (GO:0005513) | 3.50560033 |
103 | carnitine transmembrane transport (GO:1902603) | 3.46740930 |
104 | negative regulation of muscle contraction (GO:0045932) | 3.45965297 |
105 | response to inactivity (GO:0014854) | 3.45730148 |
106 | neuronal action potential propagation (GO:0019227) | 3.44825318 |
107 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.44743737 |
108 | negative regulation of protein localization to cell surface (GO:2000009) | 3.43646349 |
109 | muscle atrophy (GO:0014889) | 3.41873422 |
110 | regulation of myoblast differentiation (GO:0045661) | 3.37984802 |
111 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37884641 |
112 | muscle cell development (GO:0055001) | 3.37228434 |
113 | negative regulation of potassium ion transport (GO:0043267) | 3.36255462 |
114 | regulation of heart contraction (GO:0008016) | 3.34758897 |
115 | heart process (GO:0003015) | 3.33665522 |
116 | heart contraction (GO:0060047) | 3.33665522 |
117 | striated muscle tissue development (GO:0014706) | 3.33442886 |
118 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.33242251 |
119 | relaxation of muscle (GO:0090075) | 3.32173501 |
120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.32132349 |
121 | ubiquinone biosynthetic process (GO:0006744) | 3.31885234 |
122 | skeletal muscle adaptation (GO:0043501) | 3.30943000 |
123 | muscle contraction (GO:0006936) | 3.30642456 |
124 | myotube differentiation (GO:0014902) | 3.29385567 |
125 | glycogen catabolic process (GO:0005980) | 3.26310815 |
126 | positive regulation of heart rate (GO:0010460) | 3.24714319 |
127 | cellular carbohydrate catabolic process (GO:0044275) | 3.22687952 |
128 | positive regulation of heart contraction (GO:0045823) | 3.22020243 |
129 | oxygen transport (GO:0015671) | 3.20929606 |
130 | regulation of sulfur metabolic process (GO:0042762) | 3.18517907 |
131 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.18143859 |
132 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 3.18007229 |
133 | 2-oxoglutarate metabolic process (GO:0006103) | 3.17718375 |
134 | regulation of synapse structural plasticity (GO:0051823) | 3.16173168 |
135 | regulation of cation channel activity (GO:2001257) | 3.15554861 |
136 | amino-acid betaine transport (GO:0015838) | 3.14037932 |
137 | carnitine transport (GO:0015879) | 3.14037932 |
138 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.10403784 |
139 | muscle hypertrophy in response to stress (GO:0003299) | 3.10403784 |
140 | cardiac muscle adaptation (GO:0014887) | 3.10403784 |
141 | muscle system process (GO:0003012) | 3.07197591 |
142 | glucan catabolic process (GO:0009251) | 3.04222769 |
143 | striated muscle adaptation (GO:0014888) | 3.02760969 |
144 | sodium ion export (GO:0071436) | 2.98902189 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.22669567 |
2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.66640341 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.08535419 |
4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.06752966 |
5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.91961435 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42465135 |
7 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.39707152 |
8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.35254192 |
9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.35254192 |
10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33364895 |
11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29562903 |
12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.25169876 |
13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.12369152 |
14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.09928874 |
15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.09928874 |
16 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.09166166 |
17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.00772851 |
18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95467157 |
19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94133327 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88192644 |
21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85163666 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83761139 |
23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.82249644 |
24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.81135330 |
25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.80938006 |
26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.77891190 |
27 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.76943941 |
28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72119580 |
29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.65529926 |
30 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.61113465 |
31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60606314 |
32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59494215 |
33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59239130 |
34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57832113 |
35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55414581 |
36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48847234 |
37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47145410 |
38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45097939 |
39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44697573 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44048852 |
41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44027252 |
42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42630530 |
43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40422015 |
44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38845447 |
45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38842413 |
46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38352881 |
47 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.36594349 |
48 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.34420171 |
49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32650396 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30230910 |
51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30040778 |
52 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.29979950 |
53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.29417990 |
54 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.29191987 |
55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27830473 |
56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23553516 |
57 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21437555 |
58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19976805 |
59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19942072 |
60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19573697 |
61 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17539936 |
62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17035840 |
63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16080578 |
64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15572399 |
65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15046004 |
66 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14342196 |
67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11531857 |
68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11071453 |
69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10555274 |
70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09802021 |
71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08795647 |
72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06873007 |
73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05087086 |
74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04918687 |
75 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03723379 |
76 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02947726 |
77 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02589397 |
78 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02180385 |
79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00003572 |
80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99536725 |
81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99446381 |
82 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98863248 |
83 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98586578 |
84 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98583401 |
85 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.98477758 |
86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98168952 |
87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97178684 |
88 | AR_19668381_ChIP-Seq_PC3_Human | 0.96548442 |
89 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96503167 |
90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95654688 |
91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95191549 |
92 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94719160 |
93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94542583 |
94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93690494 |
95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93514714 |
96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93155863 |
97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92007989 |
98 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91384605 |
99 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90237489 |
100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.89802115 |
101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89771788 |
102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88841303 |
103 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.88613224 |
104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88274117 |
105 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.88160874 |
106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87029086 |
107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86480626 |
108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86479298 |
109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85601120 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83983761 |
111 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83449515 |
112 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83077165 |
113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83042413 |
114 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82852638 |
115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82812443 |
116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82476143 |
117 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81418457 |
118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81122099 |
119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80387576 |
120 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80344903 |
121 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79985222 |
122 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79540708 |
123 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.79296397 |
124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79071958 |
125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78888533 |
126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78395176 |
127 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78103616 |
128 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.77885726 |
129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77552289 |
130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77237258 |
131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77237258 |
132 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77085690 |
133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76897996 |
134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76684976 |
135 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.76467349 |
136 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.76154961 |
137 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.75900735 |
138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.75889816 |
139 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75467799 |
140 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.75247602 |
141 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75189432 |
142 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.74158830 |
143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73847764 |
144 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73776861 |
145 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.73735213 |
146 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.73371884 |
147 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72532081 |
148 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.72201745 |
149 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71593508 |
150 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.71231749 |
151 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71136809 |
152 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69052619 |
153 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.68596861 |
154 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68582753 |
155 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.67483792 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.44098362 |
2 | MP0003646_muscle_fatigue | 5.84673394 |
3 | MP0000751_myopathy | 5.41985641 |
4 | MP0004084_abnormal_cardiac_muscle | 4.65765686 |
5 | MP0004215_abnormal_myocardial_fiber | 4.32456622 |
6 | MP0004036_abnormal_muscle_relaxation | 3.97734623 |
7 | MP0000749_muscle_degeneration | 3.90989430 |
8 | MP0005451_abnormal_body_composition | 3.40067198 |
9 | MP0005330_cardiomyopathy | 3.24195006 |
10 | MP0004145_abnormal_muscle_electrophysio | 3.16029345 |
11 | MP0004087_abnormal_muscle_fiber | 2.85433356 |
12 | MP0003137_abnormal_impulse_conducting | 2.68945842 |
13 | MP0005620_abnormal_muscle_contractility | 2.66538650 |
14 | MP0002972_abnormal_cardiac_muscle | 2.65147811 |
15 | MP0002106_abnormal_muscle_physiology | 2.57479967 |
16 | MP0004130_abnormal_muscle_cell | 2.54918162 |
17 | MP0000750_abnormal_muscle_regeneration | 2.44484516 |
18 | MP0002269_muscular_atrophy | 2.39622797 |
19 | MP0008775_abnormal_heart_ventricle | 2.37604982 |
20 | MP0000747_muscle_weakness | 2.37025600 |
21 | MP0004484_altered_response_of | 2.29683807 |
22 | MP0005385_cardiovascular_system_phenoty | 2.15837067 |
23 | MP0001544_abnormal_cardiovascular_syste | 2.15837067 |
24 | MP0004859_abnormal_synaptic_plasticity | 2.15567637 |
25 | MP0002822_catalepsy | 2.11386697 |
26 | MP0000759_abnormal_skeletal_muscle | 2.10905448 |
27 | MP0005369_muscle_phenotype | 2.10195433 |
28 | MP0006138_congestive_heart_failure | 2.07093479 |
29 | MP0010630_abnormal_cardiac_muscle | 2.04649403 |
30 | MP0004085_abnormal_heartbeat | 2.02151117 |
31 | MP0004510_myositis | 1.91720393 |
32 | MP0004233_abnormal_muscle_weight | 1.81397038 |
33 | MP0003828_pulmonary_edema | 1.48557177 |
34 | MP0002332_abnormal_exercise_endurance | 1.47911559 |
35 | MP0006036_abnormal_mitochondrial_physio | 1.43052157 |
36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.41866361 |
37 | MP0002127_abnormal_cardiovascular_syste | 1.26556265 |
38 | MP0005666_abnormal_adipose_tissue | 1.25583517 |
39 | MP0002909_abnormal_adrenal_gland | 1.25031715 |
40 | MP0003635_abnormal_synaptic_transmissio | 1.22109811 |
41 | MP0001661_extended_life_span | 1.13836735 |
42 | MP0009745_abnormal_behavioral_response | 1.11052799 |
43 | MP0002234_abnormal_pharynx_morphology | 1.09093115 |
44 | MP0004270_analgesia | 1.01533413 |
45 | MP0005670_abnormal_white_adipose | 1.01103732 |
46 | MP0008569_lethality_at_weaning | 1.00415661 |
47 | MP0002064_seizures | 0.98450138 |
48 | MP0009046_muscle_twitch | 0.96840005 |
49 | MP0003950_abnormal_plasma_membrane | 0.96005323 |
50 | MP0005165_increased_susceptibility_to | 0.94363329 |
51 | MP0002108_abnormal_muscle_morphology | 0.89968853 |
52 | MP0005375_adipose_tissue_phenotype | 0.89879104 |
53 | MP0003880_abnormal_central_pattern | 0.89164599 |
54 | MP0004185_abnormal_adipocyte_glucose | 0.88807997 |
55 | MP0004043_abnormal_pH_regulation | 0.87769274 |
56 | MP0004858_abnormal_nervous_system | 0.87682032 |
57 | MP0002272_abnormal_nervous_system | 0.87451071 |
58 | MP0002063_abnormal_learning/memory/cond | 0.86275869 |
59 | MP0006035_abnormal_mitochondrial_morpho | 0.85683081 |
60 | MP0005623_abnormal_meninges_morphology | 0.85564161 |
61 | MP0000343_altered_response_to | 0.85561438 |
62 | MP0003329_amyloid_beta_deposits | 0.84923712 |
63 | MP0000266_abnormal_heart_morphology | 0.84238249 |
64 | MP0005386_behavior/neurological_phenoty | 0.79802544 |
65 | MP0004924_abnormal_behavior | 0.79802544 |
66 | MP0000230_abnormal_systemic_arterial | 0.78868973 |
67 | MP0009780_abnormal_chondrocyte_physiolo | 0.74386179 |
68 | MP0000013_abnormal_adipose_tissue | 0.74311379 |
69 | MP0000372_irregular_coat_pigmentation | 0.72555762 |
70 | MP0010368_abnormal_lymphatic_system | 0.72139067 |
71 | MP0003879_abnormal_hair_cell | 0.71496724 |
72 | MP0002971_abnormal_brown_adipose | 0.68244571 |
73 | MP0001440_abnormal_grooming_behavior | 0.67001946 |
74 | MP0002572_abnormal_emotion/affect_behav | 0.66922061 |
75 | MP0003279_aneurysm | 0.64563943 |
76 | MP0005266_abnormal_metabolism | 0.64193671 |
77 | MP0002067_abnormal_sensory_capabilities | 0.63410185 |
78 | MP0004134_abnormal_chest_morphology | 0.62394592 |
79 | MP0001501_abnormal_sleep_pattern | 0.61929298 |
80 | MP0005187_abnormal_penis_morphology | 0.58784474 |
81 | MP0003045_fibrosis | 0.58573417 |
82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.58249704 |
83 | MP0000003_abnormal_adipose_tissue | 0.57384613 |
84 | MP0005535_abnormal_body_temperature | 0.56468216 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 0.55999793 |
86 | MP0001299_abnormal_eye_distance/ | 0.55602087 |
87 | MP0002078_abnormal_glucose_homeostasis | 0.54673543 |
88 | MP0008874_decreased_physiological_sensi | 0.54584379 |
89 | MP0002735_abnormal_chemical_nociception | 0.53282130 |
90 | MP0001486_abnormal_startle_reflex | 0.52858243 |
91 | MP0002128_abnormal_blood_circulation | 0.52830485 |
92 | MP0008961_abnormal_basal_metabolism | 0.52120968 |
93 | MP0003705_abnormal_hypodermis_morpholog | 0.51837341 |
94 | MP0002066_abnormal_motor_capabilities/c | 0.49121200 |
95 | MP0004147_increased_porphyrin_level | 0.49093425 |
96 | MP0009672_abnormal_birth_weight | 0.48323413 |
97 | MP0000733_abnormal_muscle_development | 0.48267608 |
98 | MP0003633_abnormal_nervous_system | 0.48236575 |
99 | MP0005167_abnormal_blood-brain_barrier | 0.47864601 |
100 | MP0004142_abnormal_muscle_tone | 0.46710439 |
101 | MP0002638_abnormal_pupillary_reflex | 0.46068054 |
102 | MP0002734_abnormal_mechanical_nocicepti | 0.45501654 |
103 | MP0001346_abnormal_lacrimal_gland | 0.44943210 |
104 | MP0001970_abnormal_pain_threshold | 0.44454991 |
105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42927563 |
106 | MP0005423_abnormal_somatic_nervous | 0.42284915 |
107 | MP0003075_altered_response_to | 0.39521558 |
108 | MP0003566_abnormal_cell_adhesion | 0.39388754 |
109 | MP0001529_abnormal_vocalization | 0.37212973 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.36452459 |
111 | MP0005452_abnormal_adipose_tissue | 0.36358446 |
112 | MP0005166_decreased_susceptibility_to | 0.36344283 |
113 | MP0005595_abnormal_vascular_smooth | 0.34674061 |
114 | MP0005083_abnormal_biliary_tract | 0.34556474 |
115 | MP0003631_nervous_system_phenotype | 0.34152442 |
116 | MP0002733_abnormal_thermal_nociception | 0.34081038 |
117 | MP0002114_abnormal_axial_skeleton | 0.34003486 |
118 | MP0002184_abnormal_innervation | 0.33941141 |
119 | MP0000762_abnormal_tongue_morphology | 0.32221827 |
120 | MP0010030_abnormal_orbit_morphology | 0.31814971 |
121 | MP0003948_abnormal_gas_homeostasis | 0.30448712 |
122 | MP0009250_abnormal_appendicular_skeleto | 0.28878485 |
123 | MP0005334_abnormal_fat_pad | 0.27858090 |
124 | MP0006276_abnormal_autonomic_nervous | 0.25131823 |
125 | MP0001943_abnormal_respiration | 0.24023321 |
126 | MP0005319_abnormal_enzyme/_coenzyme | 0.23699569 |
127 | MP0005645_abnormal_hypothalamus_physiol | 0.23664487 |
128 | MP0005332_abnormal_amino_acid | 0.23467097 |
129 | MP0002896_abnormal_bone_mineralization | 0.23389457 |
130 | MP0002876_abnormal_thyroid_physiology | 0.14760088 |
131 | MP0003959_abnormal_lean_body | 0.14429836 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.52132813 |
2 | Exercise-induced myalgia (HP:0003738) | 6.66831540 |
3 | Calf muscle hypertrophy (HP:0008981) | 6.50558919 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.30542706 |
5 | Ventricular tachycardia (HP:0004756) | 6.22779755 |
6 | Exercise-induced muscle cramps (HP:0003710) | 6.22266354 |
7 | Distal arthrogryposis (HP:0005684) | 5.73739739 |
8 | Muscle fiber splitting (HP:0003555) | 5.58116532 |
9 | Atrial fibrillation (HP:0005110) | 5.42841450 |
10 | Abnormality of the calf musculature (HP:0001430) | 5.16395609 |
11 | Primary atrial arrhythmia (HP:0001692) | 5.11995530 |
12 | Hyporeflexia of lower limbs (HP:0002600) | 4.93752054 |
13 | Supraventricular tachycardia (HP:0004755) | 4.92354858 |
14 | Myoglobinuria (HP:0002913) | 4.90528557 |
15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.88256307 |
16 | Bundle branch block (HP:0011710) | 4.87581476 |
17 | Supraventricular arrhythmia (HP:0005115) | 4.81440598 |
18 | Right ventricular cardiomyopathy (HP:0011663) | 4.78020000 |
19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.59971666 |
20 | Subaortic stenosis (HP:0001682) | 4.59971666 |
21 | Syncope (HP:0001279) | 4.58413658 |
22 | Round ear (HP:0100830) | 4.56597819 |
23 | Lipoatrophy (HP:0100578) | 4.44874576 |
24 | Difficulty running (HP:0009046) | 4.42246986 |
25 | EMG: myopathic abnormalities (HP:0003458) | 4.30683495 |
26 | Ulnar deviation of the wrist (HP:0003049) | 4.27172572 |
27 | Ventricular fibrillation (HP:0001663) | 4.24869177 |
28 | Palpitations (HP:0001962) | 4.08970092 |
29 | Prolonged QT interval (HP:0001657) | 4.08542826 |
30 | Myotonia (HP:0002486) | 4.04073384 |
31 | Ventricular arrhythmia (HP:0004308) | 3.97739973 |
32 | Increased connective tissue (HP:0009025) | 3.93432151 |
33 | Heart block (HP:0012722) | 3.82083570 |
34 | Calcaneovalgus deformity (HP:0001848) | 3.79822743 |
35 | Dilated cardiomyopathy (HP:0001644) | 3.78180496 |
36 | Asymmetric septal hypertrophy (HP:0001670) | 3.62766399 |
37 | Abnormal atrioventricular conduction (HP:0005150) | 3.58551927 |
38 | Rhabdomyolysis (HP:0003201) | 3.56470993 |
39 | Atrioventricular block (HP:0001678) | 3.50861363 |
40 | Absent phalangeal crease (HP:0006109) | 3.46671552 |
41 | Deformed tarsal bones (HP:0008119) | 3.36022146 |
42 | Abnormal EKG (HP:0003115) | 3.35486530 |
43 | Difficulty climbing stairs (HP:0003551) | 3.27392523 |
44 | Muscle stiffness (HP:0003552) | 3.10461777 |
45 | Malignant hyperthermia (HP:0002047) | 3.02353426 |
46 | Dysmetric saccades (HP:0000641) | 2.91191172 |
47 | Muscle fiber inclusion bodies (HP:0100299) | 2.89031095 |
48 | Abnormal finger flexion creases (HP:0006143) | 2.88711438 |
49 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.83923333 |
50 | Left ventricular hypertrophy (HP:0001712) | 2.82923238 |
51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.82919525 |
52 | Slender build (HP:0001533) | 2.73137094 |
53 | Bulbar palsy (HP:0001283) | 2.62841629 |
54 | Type 1 muscle fiber predominance (HP:0003803) | 2.61542425 |
55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.57478900 |
56 | Limb-girdle muscle atrophy (HP:0003797) | 2.57149610 |
57 | Fetal akinesia sequence (HP:0001989) | 2.52144264 |
58 | Neck muscle weakness (HP:0000467) | 2.51688021 |
59 | Weak cry (HP:0001612) | 2.39221851 |
60 | Areflexia of lower limbs (HP:0002522) | 2.36935795 |
61 | Palmoplantar keratoderma (HP:0000982) | 2.35436593 |
62 | Ketoacidosis (HP:0001993) | 2.34328001 |
63 | Distal lower limb muscle weakness (HP:0009053) | 2.34094770 |
64 | Spinal rigidity (HP:0003306) | 2.33287844 |
65 | Progressive muscle weakness (HP:0003323) | 2.32090216 |
66 | Muscular dystrophy (HP:0003560) | 2.22713917 |
67 | Fatigable weakness (HP:0003473) | 2.20532959 |
68 | Abnormality of the neuromuscular junction (HP:0003398) | 2.20532959 |
69 | Distal lower limb amyotrophy (HP:0008944) | 2.19812966 |
70 | Abnormality of the calcaneus (HP:0008364) | 2.17220696 |
71 | Testicular atrophy (HP:0000029) | 2.15766057 |
72 | Focal motor seizures (HP:0011153) | 2.13153253 |
73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11159489 |
74 | Hypoplastic ischia (HP:0003175) | 2.10729290 |
75 | Waddling gait (HP:0002515) | 2.09377120 |
76 | Nemaline bodies (HP:0003798) | 2.08043281 |
77 | Rimmed vacuoles (HP:0003805) | 2.05766680 |
78 | EMG: neuropathic changes (HP:0003445) | 2.03657686 |
79 | Hip contracture (HP:0003273) | 2.03651684 |
80 | Pheochromocytoma (HP:0002666) | 2.02934047 |
81 | Acute necrotizing encephalopathy (HP:0006965) | 2.00874809 |
82 | Lower limb amyotrophy (HP:0007210) | 1.99671572 |
83 | Proximal amyotrophy (HP:0007126) | 1.99072040 |
84 | Increased muscle lipid content (HP:0009058) | 1.97169549 |
85 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.95195284 |
86 | Hepatic necrosis (HP:0002605) | 1.94318428 |
87 | Gowers sign (HP:0003391) | 1.93743614 |
88 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92614277 |
89 | Sudden cardiac death (HP:0001645) | 1.92522802 |
90 | Abnormality of the foot musculature (HP:0001436) | 1.92204691 |
91 | Facial diplegia (HP:0001349) | 1.91828924 |
92 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91446529 |
93 | Foot dorsiflexor weakness (HP:0009027) | 1.90145903 |
94 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.89953301 |
95 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.89953301 |
96 | Shoulder girdle muscle weakness (HP:0003547) | 1.87462989 |
97 | Pelvic girdle muscle weakness (HP:0003749) | 1.86701821 |
98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84496207 |
99 | Scapular winging (HP:0003691) | 1.84357241 |
100 | Large for gestational age (HP:0001520) | 1.82625889 |
101 | Myokymia (HP:0002411) | 1.81233802 |
102 | Athetosis (HP:0002305) | 1.80871776 |
103 | Abnormality of the ischium (HP:0003174) | 1.80674484 |
104 | Central scotoma (HP:0000603) | 1.79416870 |
105 | Ragged-red muscle fibers (HP:0003200) | 1.78545111 |
106 | Neuroendocrine neoplasm (HP:0100634) | 1.77849802 |
107 | Acute encephalopathy (HP:0006846) | 1.77309390 |
108 | Myopathic facies (HP:0002058) | 1.76117775 |
109 | Hepatocellular necrosis (HP:0001404) | 1.75680373 |
110 | Long clavicles (HP:0000890) | 1.75667106 |
111 | Frequent falls (HP:0002359) | 1.74999116 |
112 | Rapidly progressive (HP:0003678) | 1.73854176 |
113 | Broad metatarsal (HP:0001783) | 1.73590415 |
114 | Congestive heart failure (HP:0001635) | 1.73413116 |
115 | Paralysis (HP:0003470) | 1.73112711 |
116 | Limb-girdle muscle weakness (HP:0003325) | 1.70437603 |
117 | Increased intramyocellular lipid droplets (HP:0012240) | 1.70021952 |
118 | Generalized muscle weakness (HP:0003324) | 1.68414346 |
119 | Bradycardia (HP:0001662) | 1.67919239 |
120 | Progressive macrocephaly (HP:0004481) | 1.67515732 |
121 | Hyperkalemia (HP:0002153) | 1.66956716 |
122 | Nonprogressive disorder (HP:0003680) | 1.65736287 |
123 | Conjunctival hamartoma (HP:0100780) | 1.64661872 |
124 | Ketosis (HP:0001946) | 1.63795840 |
125 | Visual hallucinations (HP:0002367) | 1.62981142 |
126 | Dysdiadochokinesis (HP:0002075) | 1.61329187 |
127 | Cholelithiasis (HP:0001081) | 1.60059345 |
128 | Oligomenorrhea (HP:0000876) | 1.59722924 |
129 | Mitochondrial inheritance (HP:0001427) | 1.59423694 |
130 | Exercise intolerance (HP:0003546) | 1.58509269 |
131 | Metatarsus adductus (HP:0001840) | 1.50082114 |
132 | Ulnar deviation of finger (HP:0009465) | 1.49236311 |
133 | Type 2 muscle fiber atrophy (HP:0003554) | 1.44411383 |
134 | Steppage gait (HP:0003376) | 1.42546447 |
135 | Popliteal pterygium (HP:0009756) | 1.41432443 |
136 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.35471894 |
137 | Limited hip movement (HP:0008800) | 1.34935137 |
138 | Muscle fiber atrophy (HP:0100295) | 1.33871790 |
139 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.24754466 |
140 | Congenital hip dislocation (HP:0001374) | 1.24167939 |
141 | Diaphragmatic weakness (HP:0009113) | 1.23393597 |
142 | Achilles tendon contracture (HP:0001771) | 1.23369482 |
143 | Abnormality of potassium homeostasis (HP:0011042) | 1.20089397 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.38749086 |
2 | PHKG2 | 4.74396138 |
3 | PHKG1 | 4.74396138 |
4 | OBSCN | 3.82554756 |
5 | LMTK2 | 3.79810152 |
6 | DMPK | 2.77245157 |
7 | MYLK | 2.71395915 |
8 | PDK4 | 2.69756152 |
9 | PDK3 | 2.69756152 |
10 | PIK3CG | 2.65738883 |
11 | PINK1 | 2.30332943 |
12 | PKN2 | 2.12717690 |
13 | TRIB3 | 2.10637252 |
14 | PIK3CA | 2.01228672 |
15 | NEK1 | 1.93818503 |
16 | MUSK | 1.90424060 |
17 | BCKDK | 1.71125074 |
18 | PDK2 | 1.62476578 |
19 | MAP3K7 | 1.56611196 |
20 | NTRK3 | 1.47199244 |
21 | PAK3 | 1.45966937 |
22 | GRK7 | 1.42860884 |
23 | CAMK2D | 1.37956597 |
24 | RIPK1 | 1.37023939 |
25 | NME1 | 1.31355347 |
26 | TIE1 | 1.27325232 |
27 | EPHA4 | 1.21152625 |
28 | STK24 | 1.17860497 |
29 | EEF2K | 1.12214944 |
30 | MAPK12 | 1.08639305 |
31 | MAP3K4 | 1.08025628 |
32 | PRKD1 | 1.06782639 |
33 | STK38 | 1.05749283 |
34 | CCNB1 | 1.00083410 |
35 | PRKAA1 | 0.99162573 |
36 | PRPF4B | 0.99162222 |
37 | MAP2K4 | 0.97165496 |
38 | MAP3K9 | 0.95351087 |
39 | LIMK1 | 0.95029726 |
40 | PRKCH | 0.93885978 |
41 | PAK6 | 0.91037261 |
42 | CDC42BPA | 0.90153190 |
43 | CAMK2A | 0.86372614 |
44 | KSR2 | 0.86308162 |
45 | PKN1 | 0.82311445 |
46 | CAMK1 | 0.82293021 |
47 | PRKAA2 | 0.82174860 |
48 | ROCK1 | 0.80390633 |
49 | CAMK4 | 0.78712094 |
50 | WNK1 | 0.77587257 |
51 | MOS | 0.76468924 |
52 | ERBB3 | 0.75386257 |
53 | PTK2B | 0.71991679 |
54 | EPHB1 | 0.70304096 |
55 | PDGFRA | 0.69544210 |
56 | ROCK2 | 0.69287471 |
57 | PRKD3 | 0.67723113 |
58 | MAP3K5 | 0.67403171 |
59 | MAP3K13 | 0.66744093 |
60 | ILK | 0.64766776 |
61 | MAP2K3 | 0.64537091 |
62 | PDPK1 | 0.64527472 |
63 | CAMK2G | 0.61927562 |
64 | AKT2 | 0.61587112 |
65 | DYRK1B | 0.61231460 |
66 | NEK9 | 0.60524990 |
67 | PRKACB | 0.60172085 |
68 | CAMKK1 | 0.60154180 |
69 | INSRR | 0.59706795 |
70 | WNK4 | 0.58224602 |
71 | MAPK7 | 0.57737405 |
72 | PRKCE | 0.57683758 |
73 | PDK1 | 0.57568472 |
74 | DAPK3 | 0.55512705 |
75 | DAPK2 | 0.55400940 |
76 | SGK3 | 0.53685955 |
77 | MAPK11 | 0.53104846 |
78 | TRPM7 | 0.52277983 |
79 | ALK | 0.50446230 |
80 | NTRK2 | 0.50363355 |
81 | PRKACG | 0.49935217 |
82 | MAPK4 | 0.48926446 |
83 | PRKACA | 0.48264379 |
84 | MARK1 | 0.47680929 |
85 | ICK | 0.47334641 |
86 | SGK1 | 0.47313712 |
87 | TAOK1 | 0.46831511 |
88 | STK11 | 0.46364833 |
89 | MAP3K1 | 0.45916803 |
90 | JAK1 | 0.45170872 |
91 | MINK1 | 0.43726347 |
92 | CAMKK2 | 0.43088322 |
93 | CAMK2B | 0.42512987 |
94 | RET | 0.42133274 |
95 | GRK5 | 0.41077130 |
96 | FER | 0.41032286 |
97 | CDK5 | 0.40240735 |
98 | RPS6KA3 | 0.39733742 |
99 | PTK6 | 0.38594277 |
100 | MAP2K7 | 0.37929243 |
101 | NTRK1 | 0.37147687 |
102 | SGK2 | 0.34776487 |
103 | LATS2 | 0.34577763 |
104 | MAPKAPK3 | 0.34466665 |
105 | RPS6KC1 | 0.33772109 |
106 | RPS6KL1 | 0.33772109 |
107 | PRKCG | 0.32312780 |
108 | PRKG1 | 0.30432077 |
109 | SGK223 | 0.29363653 |
110 | SGK494 | 0.29363653 |
111 | MAP2K6 | 0.29318572 |
112 | MAP2K1 | 0.28962329 |
113 | TBK1 | 0.28601947 |
114 | UHMK1 | 0.27860916 |
115 | MAPK13 | 0.26506347 |
116 | RPS6KB1 | 0.26155036 |
117 | MAPK10 | 0.23927522 |
118 | TAOK2 | 0.23743751 |
119 | CDK19 | 0.22367314 |
120 | MARK2 | 0.21533714 |
121 | EPHA3 | 0.21140460 |
122 | RPS6KA1 | 0.19508855 |
123 | SIK1 | 0.18070674 |
124 | ARAF | 0.16464869 |
125 | MAP3K10 | 0.16391614 |
126 | RPS6KB2 | 0.14636137 |
127 | MAP3K11 | 0.12059550 |
128 | MTOR | 0.11663376 |
129 | ZAP70 | 0.10565236 |
130 | MARK3 | 0.09104983 |
131 | RAF1 | 0.08340252 |
132 | RPS6KA6 | 0.07690867 |
133 | FGFR3 | 0.05941134 |
134 | MAP3K6 | 0.04239614 |
135 | BRAF | 0.03792944 |
136 | GSK3B | 0.03569509 |
137 | MAPK9 | 0.03406988 |
138 | NLK | 0.02766967 |
139 | MAPK8 | 0.02624088 |
140 | PRKDC | 0.02330574 |
141 | LATS1 | 0.01961661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.64019645 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.66967198 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.43554077 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.42539248 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27544050 |
6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.24071737 |
7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.45314176 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30288036 |
9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.16631643 |
10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.09120850 |
11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04347206 |
12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.99884886 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.84081606 |
14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74138035 |
15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.69334669 |
16 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48631495 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48322085 |
18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39595338 |
19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35475276 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34612981 |
21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30096641 |
22 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27717848 |
23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23965360 |
24 | Insulin secretion_Homo sapiens_hsa04911 | 1.22804520 |
25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20116920 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19131969 |
27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.14905767 |
28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14201405 |
29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13758173 |
30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13662605 |
31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12801083 |
32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.11504878 |
33 | Salivary secretion_Homo sapiens_hsa04970 | 1.10914615 |
34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06662244 |
35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.06389942 |
36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06331576 |
37 | Renin secretion_Homo sapiens_hsa04924 | 1.05760039 |
38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05700505 |
39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04507238 |
40 | Morphine addiction_Homo sapiens_hsa05032 | 1.00933544 |
41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00281142 |
42 | Taste transduction_Homo sapiens_hsa04742 | 1.00241063 |
43 | Insulin resistance_Homo sapiens_hsa04931 | 0.98139310 |
44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98094768 |
45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.97408325 |
46 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93244770 |
47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92631917 |
48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.92149493 |
49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91835575 |
50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91445392 |
51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90298410 |
52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85736995 |
53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84831402 |
54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83639594 |
55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81715478 |
56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79553149 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73686995 |
58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72758825 |
59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70717828 |
60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70562676 |
61 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.70551672 |
62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70117128 |
63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70073947 |
64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68735759 |
65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67194785 |
66 | Gap junction_Homo sapiens_hsa04540 | 0.66048150 |
67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64678849 |
68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64040888 |
69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61343507 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61155538 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57815655 |
72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57434009 |
73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56823874 |
74 | Focal adhesion_Homo sapiens_hsa04510 | 0.56014344 |
75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54144638 |
76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53156798 |
77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52991697 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52907675 |
79 | Tight junction_Homo sapiens_hsa04530 | 0.51303213 |
80 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50713042 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50584151 |
82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49966483 |
83 | Long-term depression_Homo sapiens_hsa04730 | 0.49964583 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49848839 |
85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48425543 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48342219 |
87 | Bile secretion_Homo sapiens_hsa04976 | 0.47391989 |
88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45412409 |
89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45349448 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44442084 |
91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44361129 |
92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44353712 |
93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41008179 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39607660 |
95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38098988 |
96 | Lysine degradation_Homo sapiens_hsa00310 | 0.36146608 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.36040846 |
98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35228491 |
99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33757082 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33593670 |
101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33303774 |
102 | Peroxisome_Homo sapiens_hsa04146 | 0.32357842 |
103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31521721 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31492216 |
105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31214741 |
106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30237286 |
107 | Melanogenesis_Homo sapiens_hsa04916 | 0.29622388 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28897574 |
109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27592256 |
110 | Glioma_Homo sapiens_hsa05214 | 0.25549424 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22813281 |
112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.22213093 |
113 | Platelet activation_Homo sapiens_hsa04611 | 0.19763233 |
114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17339767 |
115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16030726 |
116 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15890826 |
117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14817395 |
118 | Adherens junction_Homo sapiens_hsa04520 | 0.13816354 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13640950 |
120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.13450867 |
121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.12270380 |
122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.06193086 |